Mycobacterium abscessus
Ozone therapy
Spondylodiscitis
Journal
Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
02
2020
accepted:
19
03
2020
entrez:
5
5
2020
pubmed:
5
5
2020
medline:
5
5
2020
Statut:
epublish
Résumé
The incidence of A healthy, nonimmunocompromised 43-year-old female presented with bilateral lower extremity radiculopathy. She underwent a fluoroscopically guided percutaneous ozone treatment for degenerated disc disease at the L4-L5 level. She was symptom free for 3 months duration. She then presented with severe low back pain, bilateral lower extremity radiculopathy, and spondylodiscitis at the L4-L5 level. This was treated with a L4-L5 transforaminal lumbar interbody fusion. MA was cultured from the epidural purulent material collected during the surgery. The patient was discharged on oral clarithromycin 500 mg twice daily and intravenous amikacin 500 mg twice daily for 6 weeks. The plan was to then continue oral clarithromycin for another 6 weeks till resolution of primary infection. Early diagnosis and appropriate therapy is required to treat NTM which is more prevalent in epidemic/endemic regions.
Sections du résumé
BACKGROUND
BACKGROUND
The incidence of
CASE DESCRIPTION
METHODS
A healthy, nonimmunocompromised 43-year-old female presented with bilateral lower extremity radiculopathy. She underwent a fluoroscopically guided percutaneous ozone treatment for degenerated disc disease at the L4-L5 level. She was symptom free for 3 months duration. She then presented with severe low back pain, bilateral lower extremity radiculopathy, and spondylodiscitis at the L4-L5 level. This was treated with a L4-L5 transforaminal lumbar interbody fusion. MA was cultured from the epidural purulent material collected during the surgery. The patient was discharged on oral clarithromycin 500 mg twice daily and intravenous amikacin 500 mg twice daily for 6 weeks. The plan was to then continue oral clarithromycin for another 6 weeks till resolution of primary infection.
CONCLUSION
CONCLUSIONS
Early diagnosis and appropriate therapy is required to treat NTM which is more prevalent in epidemic/endemic regions.
Identifiants
pubmed: 32363058
doi: 10.25259/SNI_50_2019
pii: SNI-11-63
pmc: PMC7193194
doi:
Types de publication
Case Reports
Langues
eng
Pagination
63Informations de copyright
Copyright: © 2020 Surgical Neurology International.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007083
pubmed: 30763316
Spinal Cord Ser Cases. 2019 May 31;5:53
pubmed: 31632711
Int J Infect Dis. 2017 Jul;60:49-56
pubmed: 28522316
APMIS. 2006 May;114(5):319-28
pubmed: 16725007
HSS J. 2016 Oct;12(3):278-283
pubmed: 27703423
BMC Pulm Med. 2019 May 24;19(1):100
pubmed: 31126264